Kanawha Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Kanawha Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,460	Closed	-$205K	–	167
2016 Q3	$205K	Hold	4,460	–	–	0.03%	161
2016 Q2	$224K	Hold	4,460	–	–	0.04%	160
2016 Q1	$239K	Buy	4,460 +60	+1%	+$3.52K	0.04%	160
2015 Q4	$289K	Hold	4,400	–	–	0.05%	136
2015 Q3	$248K	Hold	4,400	–	–	0.05%	139
2015 Q2	$260K	Hold	4,400	–	–	0.05%	145
2015 Q1	$274K	Hold	4,400	–	–	0.05%	141
2014 Q4	$253K	Hold	4,400	–	–	0.04%	140
2014 Q3	$237K	Hold	4,400	–	–	0.04%	144
2014 Q2	$231K	Hold	4,400	–	–	0.04%	149
2014 Q1	$232K	Buy	+4,400	New	+$203K	0.04%	142

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Kanawha Capital Management's TEVA Position: Q4 2016 in Review

Kanawha Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 4,460 shares — an estimated $205K sold.

Kanawha Capital Management first reported a position in TEVA in Q1 2014 and held it in 11 quarters. The position peaked at $289K in Q4 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Kanawha Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Kanawha Capital Management sold 4,460 Teva Pharmaceuticals shares in Q4 2016, an estimated $205K.
Kanawha Capital Management first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 11 quarters.
Kanawha Capital Management's Teva Pharmaceuticals position peaked at $289K in Q4 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Kanawha Capital Management's 13F filing for Q4 2016, filed 25 Jan 2017.